Literature DB >> 6753896

Acute and chronic effects of captopril therapy in patients with refractory heart failure.

W F Walsh, C L Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6753896      PMCID： PMC1427531          DOI： 10.1111/j.1365-2125.1982.tb02072.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

1.  Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance.

Authors:  J N Cohn
Journal:  Circulation       Date:  1973-07       Impact factor: 29.690

2.  Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.

Authors:  M Packer; J Meller; R Gorlin; M V Herman
Journal:  Circulation       Date:  1979-03       Impact factor: 29.690

3.  Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure.

Authors:  M Packer; J Meller; N Medina; M Yushak; R Gorlin
Journal:  N Engl J Med       Date:  1982-01-14       Impact factor: 91.245

Review 4.  Effectiveness of long-term vasodilator administration in the treatment of chronic left ventricular failure.

Authors:  J A Franciosa
Journal:  Prog Cardiovasc Dis       Date:  1982 Jan-Feb       Impact factor: 8.194

5.  Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.

Authors:  R Ader; K Chatterjee; T Ports; B Brundage; B Hiramatsu; W Parmley
Journal:  Circulation       Date:  1980-05       Impact factor: 29.690

6.  Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.

Authors:  R Davis; H S Ribner; E Keung; E H Sonnenblick; T H LeJemtel
Journal:  N Engl J Med       Date:  1979-07-19       Impact factor: 91.245

7.  Results of long-term vasodilator therapy in patients with refractory congestive heart failure.

Authors:  W F Walsh; B H Greenberg
Journal:  Circulation       Date:  1981-09       Impact factor: 29.690

8.  Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.

Authors:  V J Dzau; W S Colucci; G H Williams; G Curfman; L Meggs; N K Hollenberg
Journal:  N Engl J Med       Date:  1980-06-19       Impact factor: 91.245

Review 9.  Physiologic and pharmacologic determinants of vasodilator response: a conceptual framework for rational drug therapy for chronic heart failure.

Authors:  M Packer; T H Le Jemtel
Journal:  Prog Cardiovasc Dis       Date:  1982 Jan-Feb       Impact factor: 8.194

10.  Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.

Authors:  B Massie; T Ports; K Chatterjee; W Parmley; J Ostland; J O'Young; F Haughom
Journal:  Circulation       Date:  1981-02       Impact factor: 29.690
  10 in total
  1 in total

Review 1.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.